Quarterly Results

  • Company Name :
Nectar Lifescience Ltd Industry : (Pharmaceuticals)
  • BSE Code:
  • 532649
  • NSE Symbol:
  • NECLIFE
  • P/E(TTM):
  • 48.42
  • ISIN Demat:
  • INE023H01027
  • Div & Yield%:
  • -
  • EPS(TTM):
  • 0.76
  • Book Value(₹):
  • 48.10
  • Market Cap(₹Cr.):
  • 825.28
  • Face Value(₹):
  • 1.00
Quarters :  
Particulars December 2024 ( Cr)September 2024 ( Cr)June 2024 ( Cr)
Gross Sales 504.12 497.45 417.51
Excise Duty 49.79 69.56 58.66
Net Sales 454.33 427.88 358.85
Other Operating Income 0.65 0.21 0.45
Other Income 0.57 0.69 0.55
Total Income 455.56 428.79 359.85
Total Expenditure 410.27 384.76 319.50
PBIDT 45.28 44.02 40.35
Interest 17.12 19.81 19.98
PBDT 28.16 24.21 20.38
Depreciation 15.61 15.55 15.46
Tax 0.00 0.00 0.00
Fringe Benefit Tax 0.00 0.00 0.00
Deferred Tax 4.71 3.07 1.95
Reported Profit After Tax 7.84 5.60 2.97
Extra-ordinary Items 0.00 0.00 0.00
Adjusted Profit After Extra-ordinary item 7.84 5.60 2.97
EPS (Unit Curr.) 0.35 0.25 0.13
EPS (Adj) (Unit Curr.) 0.35 0.25 0.13
Calculated EPS (Unit Curr.) 0.35 0.25 0.13
Calculated EPS (Adj) (Unit Curr.) 0.35 0.25 0.13
Calculated EPS (Ann.) (Unit Curr.) 1.40 1.00 0.53
Calculated EPS (Adj) (Ann.) (Unit Curr.) 1.40 1.00 0.53
Book Value (Unit Curr.) 0.00 0.00 0.00
Dividend (%) 0.00 0.00 0.00
Equity 22.43 22.43 22.43
Reserve & Surplus 0.00 0.00 0.00
Face Value 1.00 1.00 1.00
Public Shareholding (No. Of Shares) 0.00 0.00 0.00
Public Shareholding (% in Equity) 0.00 0.00 0.00
Pledged/Encumbered - No. of Shares 0.00 0.00 0.00
Pledged/Encumbered - % in Total Promoters Holding 0.00 0.00 0.00
Pledged/Encumbered - % in Total Equity 0.00 0.00 0.00
Non Encumbered - No. of Shares 0.00 0.00 0.00
Non Encumbered - % in Total Promoters Holding 0.00 0.00 0.00
Non Encumbered - % in Total Equity 0.00 0.00 0.00
PBIDTM(%) 9.97 10.29 11.24
PBDTM(%) 6.20 5.66 5.68
PATM(%) 1.73 1.31 0.83